These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24237037)

  • 1. Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.
    Dassopoulos T; Dubinsky MC; Bentsen JL; Martin CF; Galanko JA; Seidman EG; Sandler RS; Hanauer SB
    Aliment Pharmacol Ther; 2014 Jan; 39(2):163-75. PubMed ID: 24237037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
    Belaiche J; Desager JP; Horsmans Y; Louis E
    Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
    Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
    Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease.
    Regueiro M; Mardini H
    J Clin Gastroenterol; 2002 Sep; 35(3):240-4. PubMed ID: 12192200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ
    Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn's disease patients.
    Zhu X; Chao K; Li M; Xie W; Zheng H; Zhang JX; Hu PJ; Huang M; Gao X; Wang XD
    World J Gastroenterol; 2019 Oct; 25(38):5850-5861. PubMed ID: 31636477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
    Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
    Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
    Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W
    Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
    Sandborn WJ; Tremaine WJ; Wolf DC; Targan SR; Sninsky CA; Sutherland LR; Hanauer SB; McDonald JW; Feagan BG; Fedorak RN; Isaacs KL; Pike MG; Mays DC; Lipsky JJ; Gordon S; Kleoudis CS; Murdock RH
    Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
    González-Lama Y; Bermejo F; López-Sanromán A; García-Sánchez V; Esteve M; Cabriada JL; McNicholl AG; Pajares R; Casellas F; Merino O; Carpio D; Vera MI; Muñoz C; Calvo M; Benito LM; Bujanda L; García-Fernández FJ; Ricart E; Ginard D; Velasco M; Carneros JA; Manceñido N; Calvo M; Algaba A; Froilan C; Cara C; Maté J; Abreu L; Gisbert JP;
    Aliment Pharmacol Ther; 2011 Sep; 34(5):544-54. PubMed ID: 21722149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Dubinsky MC; Reyes E; Ofman J; Chiou CF; Wade S; Sandborn WJ
    Am J Gastroenterol; 2005 Oct; 100(10):2239-47. PubMed ID: 16181376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
    Friedman AB; Brown SJ; Bampton P; Barclay ML; Chung A; Macrae FA; McKenzie J; Reynolds J; Gibson PR; Hanauer SB; Sparrow MP
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1092-1102. PubMed ID: 29468701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
    Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.